导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.18% | 617/1050 |
| 近一周 | -1.09% | 139/1104 |
| 近一月 | -1.09% | 155/1102 |
| 近一季 | 1.84% | 181/1092 |
| 近半年 | -4.99% | 603/1070 |
| 近一年 | -2.99% | 636/1018 |
| 近两年 | 26.09% | 717/926 |
| 近三年 | 15.58% | 543/834 |
| 成立以来 | 244.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.39% 517/1070 |
-8.88% 889/1101 |
- - |
- - |
| 2025 | 10.65% 822/1065 |
5.29% 396/1014 |
-3.93% 930/1038 |
11.54% 822/1050 |
-1.93% 552/1065 |
| 2024 | 18.69% 104/1011 |
7.66% 54/960 |
2.01% 196/983 |
14.91% 233/991 |
-5.94% 727/1011 |
| 2023 | -9.68% 319/952 |
1.91% 517/880 |
-3.03% 376/895 |
0.61% 70/915 |
-9.17% 821/952 |
| 2022 | -16.79% 214/867 |
-17.26% 381/773 |
11.70% 201/806 |
-15.29% 582/845 |
6.29% 155/867 |
| 2021 | 1.13% 343/740 |
0.84% 116/580 |
-0.03% 543/659 |
-4.35% 327/704 |
4.89% 230/740 |
| 2020 | 72.55% 133/554 |
1.13% 131/419 |
20.06% 285/466 |
18.91% 66/517 |
19.51% 126/554 |
| 2019 | 61.83% 71/410 |
29.33% 411/1149 |
1.61% 196/1231 |
8.62% 138/390 |
13.37% 83/410 |
| 2018 | -26.96% 175/349 |
- - |
- - |
- - |
-11.24% 432/1080 |
| 2017 | 15.70% 97/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.61% 59/205 |
- - |
- - |
- - |
- - |
| 2015 | 47.08% 29/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 鹏华先进制造股票 VS. 东吴新产业精选股票A(580008) |